Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px
Document › Details

Oncopeptides AB. (5/6/20). "Press Release: Oncopeptides Has Completed a Directed Share Issue Raising approximately SEK 1,414 Million (USD 144 M) [NOT FOR US, AU, CA, et al.]". Boston, MA.

Organisations Organisation Oncopeptides AB (Nasdaq Stockholm: ONCO)
  Group Oncopeptides (Group)
  Organisation 2 Deerfield (Group)
Products Product Melflufen
  Product 2 investment banking
Index term Index term Oncopeptides–SEVERAL: investment, 202005 directed share issue SEK1.414b ($144m) with 12.295m new shares at SEK115/share
Persons Person Lindberg, Jakob (Oncopeptides AB 202102 CSO before CEO)
  Person 2 Piir, Rein (Oncopeptides 201912 Head of Investor Relations)
     


   
Record changed: 2020-05-27

Advertisement

Picture [iito] Made Without Love 650x80px

More documents for Oncopeptides (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Network in German Capital Region 650x80px




» top